Ara
Toplam kayıt 33, listelenen: 21-30
Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease
(Elsevier Science Inc, 2019)
Purpose. Data on recurrence of hepatitis D virus (HDV) and its long-term impact on liver transplant (LT) are limited. in this study, we investigated the incidence of hepatitis B virus (HBV) and the long-term effect of ...
Acute Kidney Injury After Pediatric Liver Transplantation
(Elsevier Science Inc, 2019)
Background. the aim of the present study is to assess acute kidney injury (AKI) incidence according to the pRIFLE and AKIN criteria and to evaluate the risk factors for early developing AKI in postoperative intensive care ...
Postoperative Myocardial Injury Does Not Predict Early and 1-Year Mortality After Living Donor Liver Transplantation
(Elsevier Science Inc, 2019)
Background. Preoperative cardiac troponin-I (cTnI) elevation has been shown to be a predictor of mortality after liver transplantation. Myocardial injury after non-cardiac surgery (MINS) has been defined as elevation of ...
Glasgow coma scale and APACHE-II scores affect the liver transplantation outcomes in patients with acute liver failure
(ZHEJIANG UNIV SCH MEDICINE, 2013)
BACKGROUND: The timing and selection of patients for liver transplantation in acute liver failure are great challenges. This study aimed to investigate the effect of Glasgow coma scale (GCS) and APACHE-II scores on liver ...
Right-lobe Liver Transplant From Donors With Gilbert Syndrome
(BASKENT UNIV, 2012)
Objectives: Donor safety is one of the most important aspects of living-donor liver transplant. The preoperative evaluation of candidates for such transplants essentially starts with serologic and biochemical analyses. ...
The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence
(WILEY, 2016)
BackgroundThe aim of this study was to determine the long-term efficacy of nucleos(t)ide analog (NA) and low-dose hepatitis B immunoglobulin (HBIG) combination treatment for preventing post-transplant hepatitis B virus ...
Anatomical variations of donor portal vein in right lobe living donor liver transplantation: the safe use of variant portal veins
(WILEY-BLACKWELL, 2013)
In right lobe (RL) living donor liver transplantation (LDLT), portal vein (PV) variations are of immense clinical significance. In this study, we describe in detail our PV reconstruction techniques in RL grafts with variant ...
Diagnostic performances of intravoxel incoherent motion and conventional diffusion-weighted imaging in the differential diagnosis of benign and malignant portal vein thrombus
(SPRINGER, 2018)
To evaluate the diagnostic accuracy of intravoxel incoherent motion (IVIM) and diffusion-weighted imaging (DWI) parameters in the differential diagnosis of portal vein thrombus (PVT). Thirty-five patients with PVT were ...
Liver transplantation for homozygote familial hypercholesterolemia: the only curative treatment
(WILEY-BLACKWELL, 2016)
FH is an autosomal dominant genetic disorder characterized by increased TC and LDL level, which leads to xanthomas, atherosclerosis, and cardiac complications even in childhood. The treatment options are diet, medical ...
Living-donor Liver Transplant in 3 Patients With Budd-Chiari Syndrome: Case Report
(BASKENT UNIV, 2012)
Budd-Chiari syndrome is a rare but life-threatening disorder characterized by obstruction of the hepatic venous outflow. Treatment depends on the underlying cause, the location, and extent of the obstruction, and the ...